A new study published in Cancer Research reveals that healthy individuals exhibit surprisingly large differences in their organ mutation burdens, with some people carrying up to eight times more mutations than others—levels comparable to those found in cancer patients. Conducted by scientists at City of Hope and TGen, the research analyzed whole-genome and whole-exome sequencing … Read more
Inherited genetics directly shape how our DNA interacts with acquired mutations to drive tumor evolution, according to research published in Nature. Scientists at the University of Cambridge and the University of Edinburgh found that an individual’s genetic background dictates both cancer risk and the specific evolutionary paths tumors take, offering new direction for precision medicine … Read more
Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more
Researchers at the Salk Institute have developed a patient-derived organoid platform to study chronic pancreatitis, a condition affecting approximately three million people worldwide for which no cure currently exists. By generating 37 organoids from patients, the study—published in Cell Stem Cell—identified cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction as a key therapeutic target and uncovered … Read more
Directed evolution, a method for engineering enzymes by mimicking the natural process of selection, is shifting from a niche lab technique to a primary engine for industrial chemistry. According to Caltech’s Frances Arnold, who received the 2018 Nobel Prize in Chemistry for this work, the future of the field lies in integrating machine learning with … Read more
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new molecular mechanism driving hypertrophic cardiomyopathy, the most common inherited heart disease. A study published in Nature Cardiovascular Research confirms that the targeted therapy mavacamten remains effective across various genetic mutations, potentially expanding treatment options for the estimated 95,230 patients living with the … Read more
The Fragility Paradox: How Stabilizing the p53 Protein Could Redefine Cancer Therapy For decades, the scientific community has viewed the p53 protein as the “guardian of the genome.” Its primary job is to prevent tumors from forming, but when it fails, the results are often catastrophic. For a long time, the prevailing theory was that … Read more
Beyond Inhibition: The Shift Toward Total Protein Elimination For decades, the gold standard of drug discovery has been inhibition. The goal was simple: find a protein causing disease and block its activity. However, this approach has a fundamental flaw—it leaves the disease-causing protein intact, often allowing the cell to find a workaround or develop resistance. … Read more
The Brain’s Hidden Bridge: New Insights into Spatial Memory and Schizophrenia Scientists have long known the hippocampus is crucial for memory formation, but the intricate communication between its hemispheres has remained largely a mystery. Recent research, published in Cell Reports, has illuminated a specific neural pathway connecting the CA1 region of the right hippocampus to … Read more
Gene Editing Offers Novel Hope for Epilepsy Treatment: A Turning Point in Neuroscience Scientists at the University of Virginia (UVA) have achieved a significant breakthrough in epilepsy research, successfully reversing severe seizures in lab mice using a next-generation gene editing technique called base editing. This promising development, published in the Journal of Clinical Investigation, signals … Read more